Aedifica SA AED
EURONEXT · Belgium · Finance
€63.00-0.80 (-1.25%)
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Aedifica/SA has delivered a 33.4% gain over the past 3 years, yet the stock recently traded at €64.50 after a softer few months, which raises a simple question for holders and potential buyers alike. Are the cash flows from Aedifica/SA's property portfolio strong and reliable enough to make that current price look sensible? The 33.4% return over 3 years puts real money on the line for investors who now need to judge whether that outcome is backed by the stream of cash the business can...
Please find below Aedifica’s 2026 half year financial report. Creating Europe’s leading healthcare REIT On 10 March 2026, Aedifica acquired control over Cofinimmo with 80% of the shares tendered during the exchange offerOn 1 July 2026, Cofinimmo was delisted from Euronext following a legal merger by absorption with AedificaA new Board of Directors and Executive Committee have been appointed Robust operational performance driving strong results EPRA Earnings per share increased to €2.71 (+5% comp
Please find below Aedifica’s interim financial report for the 1st quarter of the 2026 financial year. Creating Europe’s leading healthcare REIT Aedifica acquired control over Cofinimmo on 10 March 2026, with 80% of the shares tendered during the exchange offerA new Board of Directors has been appointedThe newly composed Executive Committee has been appointed and will be effective as of the legal mergerExtraordinary general meetings of Aedifica and Cofinimmo are convened in June to approve the me
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.